1.62
1.25%
0.02
アフターアワーズ:
1.50
-0.12
-7.41%
Evogene Ltd (EVGN) 最新ニュース
Evogene Ltd. (NASDAQ:EVGN) Q3 2024 Earnings Call Transcript - Insider Monkey
Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities - Investing.com Canada
Evogene Schedules Third Quarter 2024 Financial Results Release - GuruFocus.com
Casterra Announces a Key Milestone in its Operational Expansion - GuruFocus.com
Evogene Q3 2024 Earnings Preview - MSN
Evogene Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Evogene earnings missed by $0.30, revenue fell short of estimates - Investing.com India
Evogene Sees Revenue Growth and Expands AI Collaboration - TipRanks
SEC Form 424B3 filed by Evogene Ltd - Quantisnow
Evogene Reports Third Quarter 2024 Financial Results - PR Newswire
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results - Marketscreener.com
Finansavisen - Finansavisen
Evogene stock hits 52-week low at $1.7 amid market challenges - Investing.com India
Lavie Bio Announces Commercial Expansion of Yalos as Seed-Treatment for Soybean, Following Successful Field Trials - Krishak Jagat English
Evogene subsidiary Lavie Bio announces commercial expansion of Yalos treatment - TipRanks
Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials - WV News
Evogene (EVGN) to Report Q3 2024 Results, Hosts Virtual Conference Call Nov 21 | EVGN Stock News - StockTitan
II: Exploring 🧭 TechBio - substack.com
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design - Krishak Jagat English
Evogene and Google Cloud Partner to Develop AI Foundation Model for Drug Discovery - HIT Consultant
Evogene stock hits 52-week low at $2.13 amid market challenges - Investing.com Australia
500: Something went wrong - Investing.com
Evogene partners with Google Cloud for AI-driven molecule design By Investing.com - Investing.com Australia
Evogene partners with Google Cloud for AI-driven molecule design - Investing.com India
Biomica to Present at Digestive Disease Week (DDW) Conference 20 - GuruFocus.com
Evogene announces collaboration with Google Cloud - MSN
Syngenta and Lavie Bio Announce Partnership to Discover and Deve - GuruFocus.com
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya - Krishak Jagat English
Evogene Ltd. (NASDAQ:EVGN) Sees Significant Growth in Short Interest - MarketBeat
Evogene (NASDAQ:EVGN) Stock Crosses Below 200-Day Moving AverageShould You Sell? - MarketBeat
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - MarketBeat
Evogene stock hits 52-week low at $2.21 amid market challenges - Investing.com Nigeria
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Watershed, Evogene, and BGU to Expand Gene Editing Applications to White Leg Shrimp and Red Swamp Crayfish - ISAAA
Evogene (NASDAQ:EVGN) Shares Pass Below Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Evogene (NASDAQ:EVGN) Research Coverage Started at StockNews.com - MarketBeat
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology - PR Newswire
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals - Krishak Jagat English
Lavie Bio receives grant to advance ag-biologicals tech - World Bio Market Insights
Evogene (NASDAQ:EVGN) Stock Price Crosses Below 200 Day Moving Average of $5.81 - MarketBeat
StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - MarketBeat
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals - Lelezard
大文字化:
|
ボリューム (24 時間):